Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Vectren Corporation has obtained a Fair Price in its Sale to CenterPoint Energy, Inc.

MILWAUKEE, April 23, 2018 /PRNewswire/ — Ademi & O’Reilly, LLP is investigating the Board of Directors of Vectren Corporation (NYSE: VVC) for possible breaches of fiduciary duty and other violations of Indiana law in connection with the sale of Vectren to CenterPoint Energy, Inc.

Click here to learn how to join the action: http://ademilaw.com/case/vectren or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

Ademi & O’Reilly, LLP alleges Vectren’s long-term financial outlook is improving and yet Vectren shareholders will receive only $72 for each share of Vectren common stock they own. CenterPoint is well aware of Vectren’s improving financial metrics and is purchasing Vectren at a substantial discount. The merger agreement unreasonably limits competing bids for Vectren by (i) prohibiting solicitation of any further bids, and (ii) imposing a termination penalty should Vectren receive and accept a superior bid. Vectren insiders, their affiliates and other major shareholders own significant voting stock, and will receive millions of dollars as part of change of control arrangements, and therefore can unduly influence a sale of Vectren. Our investigation centers on the conduct of Vectren’s Board of Directors, who have unanimously approved the transaction, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Vectren given its current financial condition and prospects.

If you own common stock in Vectren and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or http://ademilaw.com/case/vectren.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts